| Literature DB >> 32096649 |
Sonja L Knowles1, Huzefa A Raja1, Israa H Isawi1, Laura Flores-Bocanegra1, Patricia H Reggio1, Cedric J Pearce2, Joanna E Burdette3, Antonis Rokas4, Nicholas H Oberlies1.
Abstract
Wheldone (1) was isolated and elucidated from a coculture of Aspergillus fischeri (NRRL 181) and Xylaria flabelliformis (G536), where secondary metabolite biosynthesis was stimulated by antagonism between these fungi. First observed via in situ analysis between these competing fungal cultures, the conditions were scaled to reproducibly generate 1, whose novel structure was elucidated by one- and two-dimensional NMR and mass spectrometry. Compound 1 displayed cytotoxic activity against breast, ovarian, and melanoma cancer cell lines.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32096649 PMCID: PMC7153779 DOI: 10.1021/acs.orglett.0c00219
Source DB: PubMed Journal: Org Lett ISSN: 1523-7052 Impact factor: 6.005
Figure 1Wheldone (1) was isolated from the coculture of Aspergillus fischeri and Xylaria flabelliformis.
Figure 2(A) Wheldone (1) was first noted as a minor component in the base peak chromatogram during in situ analysis[22] of the junction that developed between A. fischeri and X. flabelliformis (shown in the box in the coculture Petri dish at the right). (B) Base peak chromatogram of the scaled-up coculture experiment (250 mL Erlenmeyer flasks), with the inset showing the mass spectrum of 1 and its adducts. Note that the chromatographic conditions were different between panels A (in situ analysis) and B (UPLC–MS), which is why the retention time of 1 varies.
1H (700 MHz), 13C (175 MHz), and HMBC NMR Data for 1 in CD3OD
| pos | δC, type | δH (J, Hz) | HMBC (H → C) |
|---|---|---|---|
| 1 | 172.2, C | ||
| 2 | 122.6, CH | 5.71 (d, 15.97) | 4, 1 |
| 3 | 137.4, CH | 7.40 (d, 16.00) | 6, 2, 4, 5, 1 |
| 4 | 137.1, C | ||
| 5 | 142.8, CH | 6.46 (t, 1.96) | 6, 7, 3, 4 |
| 6 | 74.8, CH2 | 4.75 (dd, 12.01, 1.30) | 4, 5 |
| 4.81 (dd, 12.01, 1.03) | |||
| 7 | 95.2, C | ||
| 8 | 76.1, CH | 3.54 (d, 10.41) | 23, 9, 7, 19 |
| 9 | 43.0, CH | 3.84 (dd, 10.45, 2.12) | 15, 10, 8, 7, 17, 19 |
| 10 | 44.0, CH | 1.96 (dt, 10.78, 3.49) | 16 |
| 11 | 31.6, CH | 1.19 (m) | |
| 12 | 36.4, CH2 | 0.94 (dq, 12.82, 2.63) | |
| 1.56 (m) | |||
| 13 | 23.5, CH2 | 1.23 (m) | |
| 1.48 (m) | |||
| 14 | 32.8, CH2 | 1.50 (m) | |
| 1.74 (m) | |||
| 15 | 34.6, CH | 2.88 (br s) | |
| 16 | 142.9, CH | 5.81 (br s) | 25, 14, 10, 19 |
| 17 | 133.6, C | ||
| 18 | 121.9, CH | 6.57 (s) | 9, 8, 17, 19, 20 |
| 19 | 157.3, C | ||
| 20 | 208.7, C | ||
| 21 | 74.2, CH | 4.41 (q, 7.04) | 22, 20 |
| 22 | 20.8, CH3 | 1.35 (d, 7.04) | 21, 20 |
| 23 | 19.3, CH3 | 1.42 (s) | 8, 7, 5 |
| 24 | 20.5, CH3 | 0.78 (d, 6.47) | 11, 12, 10 |
| 25 | 20.0, CH3 | 1.91 (d, 1.11) | 17, 16, 19 |
Figure 3Key COSY and HMBC correlations for 1.
Figure 4ΔδH values (Δδ = δ – δ) obtained for (S)- and (R)-MTPA esters of wheldone (1) (1a and 1b, respectively) in pyridine-d5.
Activity of 1 against Three Tumor Cell Lines
| IC50 (μM) | |||
|---|---|---|---|
| compd | MDA-MB-231 | OVCAR-3 | MDA-MB-435 |
| 7.6 | 3.8 | 2.4 | |
| taxol | 0.17 | 0.0051 | 0.00043 |
IC50 values were determined as the concentration required to inhibit growth to 50% of control with a 72 h incubation.